| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |